Details for Patent: 8,945,592
Which drugs does patent 8,945,592 protect, and when does it expire?
Patent 8,945,592 protects DSUVIA and is included in one NDA.
This patent has seventeen patent family members in sixteen countries.
Summary for Patent: 8,945,592
| Title: | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
| Abstract: | Compositions and methods effective to minimize or eliminate the presence of oxidative degradation products in solid dosage forms comprising sufentanil are provided. |
| Inventor(s): | Shamim Pushpala, Larry Hamel, Stelios Tzannis, Evangeline Cruz |
| Assignee: | Vertical Pharmaceuticals LLC |
| Application Number: | US12/275,485 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Dosage form; |
Drugs Protected by US Patent 8,945,592
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertical Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,945,592
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009316874 | ⤷ Start Trial | |||
| Brazil | PI0921519 | ⤷ Start Trial | |||
| Canada | 2743261 | ⤷ Start Trial | |||
| China | 102231980 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
